chr3-58430811-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000925.4(PDHB):​c.435A>G​(p.Arg145Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.997 in 1,614,196 control chromosomes in the GnomAD database, including 802,407 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.98 ( 73904 hom., cov: 32)
Exomes 𝑓: 1.0 ( 728503 hom. )

Consequence

PDHB
NM_000925.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.293

Publications

19 publications found
Variant links:
Genes affected
PDHB (HGNC:8808): (pyruvate dehydrogenase E1 subunit beta) The pyruvate dehydrogenase (PDH) complex is a nuclear-encoded mitochondrial multienzyme complex that catalyzes the overall conversion of pyruvate to acetyl-CoA and carbon dioxide, and provides the primary link between glycolysis and the tricarboxylic acid (TCA) cycle. The PDH complex is composed of multiple copies of three enzymatic components: pyruvate dehydrogenase (E1), dihydrolipoamide acetyltransferase (E2) and lipoamide dehydrogenase (E3). The E1 enzyme is a heterotetramer of two alpha and two beta subunits. This gene encodes the E1 beta subunit. Mutations in this gene are associated with pyruvate dehydrogenase E1-beta deficiency. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2012]
PDHB Gene-Disease associations (from GenCC):
  • pyruvate dehydrogenase E1-beta deficiency
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Leigh syndrome
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 3-58430811-T-C is Benign according to our data. Variant chr3-58430811-T-C is described in ClinVar as Benign. ClinVar VariationId is 559256.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.293 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.993 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PDHBNM_000925.4 linkc.435A>G p.Arg145Arg synonymous_variant Exon 6 of 10 ENST00000302746.11 NP_000916.2 P11177-1A0A384MDR8
PDHBNM_001315536.2 linkc.381A>G p.Arg127Arg synonymous_variant Exon 5 of 9 NP_001302465.1 P11177-2
PDHBNR_033384.2 linkn.541A>G non_coding_transcript_exon_variant Exon 5 of 9
PDHBNM_001173468.2 linkc.404-23A>G intron_variant Intron 6 of 10 NP_001166939.1 P11177-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PDHBENST00000302746.11 linkc.435A>G p.Arg145Arg synonymous_variant Exon 6 of 10 1 NM_000925.4 ENSP00000307241.6 P11177-1

Frequencies

GnomAD3 genomes
AF:
0.985
AC:
149894
AN:
152204
Hom.:
73848
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.948
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.994
Gnomad ASJ
AF:
1.00
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
1.00
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
0.991
Gnomad NFE
AF:
0.999
Gnomad OTH
AF:
0.985
GnomAD2 exomes
AF:
0.996
AC:
250445
AN:
251488
AF XY:
0.997
show subpopulations
Gnomad AFR exome
AF:
0.947
Gnomad AMR exome
AF:
0.997
Gnomad ASJ exome
AF:
1.00
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
1.00
Gnomad NFE exome
AF:
1.00
Gnomad OTH exome
AF:
0.998
GnomAD4 exome
AF:
0.998
AC:
1459397
AN:
1461874
Hom.:
728503
Cov.:
54
AF XY:
0.999
AC XY:
726176
AN XY:
727238
show subpopulations
African (AFR)
AF:
0.949
AC:
31777
AN:
33476
American (AMR)
AF:
0.997
AC:
44577
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
26136
AN:
26136
East Asian (EAS)
AF:
1.00
AC:
39698
AN:
39700
South Asian (SAS)
AF:
1.00
AC:
86251
AN:
86258
European-Finnish (FIN)
AF:
1.00
AC:
53408
AN:
53418
Middle Eastern (MID)
AF:
0.997
AC:
5749
AN:
5768
European-Non Finnish (NFE)
AF:
1.00
AC:
1111628
AN:
1111998
Other (OTH)
AF:
0.996
AC:
60173
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
139
278
418
557
696
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21670
43340
65010
86680
108350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.985
AC:
150009
AN:
152322
Hom.:
73904
Cov.:
32
AF XY:
0.986
AC XY:
73424
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.948
AC:
39400
AN:
41552
American (AMR)
AF:
0.994
AC:
15218
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
3472
AN:
3472
East Asian (EAS)
AF:
1.00
AC:
5180
AN:
5180
South Asian (SAS)
AF:
1.00
AC:
4825
AN:
4826
European-Finnish (FIN)
AF:
1.00
AC:
10624
AN:
10624
Middle Eastern (MID)
AF:
0.986
AC:
290
AN:
294
European-Non Finnish (NFE)
AF:
0.999
AC:
68005
AN:
68044
Other (OTH)
AF:
0.985
AC:
2083
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
115
230
344
459
574
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
914
1828
2742
3656
4570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.992
Hom.:
49854
Bravo
AF:
0.983
Asia WGS
AF:
0.998
AC:
3469
AN:
3478
EpiCase
AF:
1.00
EpiControl
AF:
1.00

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Pyruvate dehydrogenase E1-beta deficiency Benign:3
Jun 15, 2021
Pars Genome Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Feb 23, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Pyruvate dehydrogenase phosphatase deficiency Benign:1
Nov 16, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.58
CADD
Benign
11
DANN
Benign
0.84
PhyloP100
-0.29
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4264746; hg19: chr3-58416538; COSMIC: COSV108138100; COSMIC: COSV108138100; API